A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax).

Clinical trial NCT01021358 · COMPLETED

Trial details

NCT number: NCT01021358
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Chronic Lymphocytic Leukemia Solid Tumors

Start date: 2010-01-01
Primary completion: 2010-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.